Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -66.8% | n/a |
ROCE | 134.9% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.1 | n/a |
Pr/Book | 0.4 |
Latest | F'cast | |
---|---|---|
Revenue | 2176.7% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | n/a | (0.07) | (0.06)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 0.01 | (0.76) | (0.36)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 0.04 | (0.42) | (1.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 0.06 | (0.34) | (1,620.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 1.37 | (1.34) | (1.39)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Acuity RM Group Plc - Issue of Equity | 21-May-2025 | 07:00 | PR Newswire |
Acuity RM Group Plc - Issue of Equity | 19-May-2025 | 09:45 | PR Newswire |
Acuity RM Group Plc - Issue of Equity | 19-May-2025 | 07:00 | PR Newswire |
Acuity RM buys Rizikon software from collapsed C... | 19-Nov-2024 | ShareCast |
Acuity RM reports recent strategic progress | 10-Jul-2024 | ShareCast |
Acuity RM appoints new finance director | 14-Jun-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.08p |
Change Today | 0.075p |
% Change | 7.50 % |
52 Week High | 4.45 |
52 Week Low | 0.97 |
Volume | 451,287 |
Shares Issued | 150.13m |
Market Cap | £1.61m |
Beta | 0.23 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:15 | 100,000 @ 1.03p |
15:13 | 111 @ 1.04p |
14:11 | 452 @ 1.04p |
13:30 | 724 @ 1.04p |
12:28 | 250,000 @ 0.97p |
Finance Director | Katherine Buchan ACA |
CEO | David Rajakovich |
You are here: research